{"id":5722,"date":"2026-03-30T18:13:24","date_gmt":"2026-03-30T15:13:24","guid":{"rendered":"https:\/\/www.sightsciences.com\/us\/?p=5722"},"modified":"2026-03-30T23:22:52","modified_gmt":"2026-03-30T20:22:52","slug":"sight-sciences-secures-order-on-post-trial-motions-that-preserves-the-jurys-verdict-and-awards-monetary-damages-to-sight-sciences-against-alcon-and-its-hydrus-microstent","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/us\/sight-sciences-secures-order-on-post-trial-motions-that-preserves-the-jurys-verdict-and-awards-monetary-damages-to-sight-sciences-against-alcon-and-its-hydrus-microstent\/","title":{"rendered":"Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury\u2019s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus\u00ae Microstent"},"content":{"rendered":"\n
\n
\n
\n
\n
\n
\n
<\/div>\n
\n
\n

\n
\n
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury\u2019s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus\u00ae Microstent<\/div>\n<\/p><\/div>\n<\/h2>\n
\n
\n
\n
<\/div>\n<\/p><\/div>\n<\/div>\n
\n
\n PDF Version<\/a><\/span>\n<\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n

Court preserves jury\u2019s finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028<\/h3>\n

MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Sight Sciences, Inc<\/a>. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients\u2019 lives, today announced that the U.S. District Court for the District of Delaware (the Court) issued an order on post-trial motions in Sight Sciences\u2019 patent infringement case against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc. (collectively, Alcon) originally filed on September 16, 2021, that preserved the jury\u2019s verdict of willful infringement. Sight Sciences asserted that Alcon\u2019s sale of the Hydrus\u00ae Microstent (Hydrus) infringed three Sight Sciences patents.<\/p>\n

The Court\u2019s order was entered on March 27, 2026. The order (i) did not disturb the jury\u2019s verdict that Alcon willfully infringed all three of Sight Sciences\u2019 asserted patents and (ii) awarded monetary damages of $34 million, plus supplemental damages and interest, for past infringement, plus an ongoing royalty of 10% of Hydrus revenue through November 10, 2028, the date of expiration of Sight Sciences\u2019 last asserted patent. A final judgment is expected to be entered by the Court in the coming months after supplemental damages and pre-judgment interest have been calculated. The Court\u2019s final judgment is subject to appeal by Alcon.<\/p>\n

Judgment Overview<\/strong><\/p>\n